🛰️ Daily AI Frontier
‹ back to 2026-08-20

Mol Cell | 朱广李等揭示尤文肉瘤中EWS-FLI1通过双重机制摧毁POLQ剪接与功能,导致MMEJ缺陷

Research Medical/Healthcare AI

Ranking

Overall 77
Content 80
Popularity 71

Observed public metrics from 1 member.

Representative image for Mol Cell | 朱广李等揭示尤文肉瘤中EWS-FLI1通过双重机制摧毁POLQ剪接与功能,导致MMEJ缺陷

Merged summary

TL;DR - A Molecular Cell study identifies Ewing sarcoma as an MMEJ-deficient cancer and shows that EWS-FLI1 disables POLQ/Pol θ through defective exon 25 splicing and impaired DNA-repair foci formation. This creates targetable dependencies on alternative DNA-repair pathways and may provide a biomarker for treatment selection.

  • EWSR1, FUBP1, and KHSRP normally bind a six-nucleotide enhancer in POLQ exon 25 to preserve correct splicing and functional Pol θ expression.
  • EWS-FLI1 sequesters EWSR1 away from this enhancer, causing exon 25 skipping, while independently disrupting Pol θ recruitment to mitotic DNA-break sites.
  • Correcting POLQ splicing restored MMEJ activity and reversed sensitivity to DNA-repair inhibitors, establishing a direct causal link.
  • Ewing sarcoma models were selectively vulnerable to RBM39 degraders, CDK12 inhibitors, and DNA-PK inhibition combined with etoposide.

Sources (1)

Mol Cell | 朱广李等揭示尤文肉瘤中EWS-FLI1通过双重机制摧毁POLQ剪接与功能,导致MMEJ缺陷

WeChat: BioArt 2026-08-21 doi:10.1038/s43018-021-00203-x
Public signals OpenAlex citations 350
Providers: Hugging Face · N/A OpenAlex · Citations 350 Publisher · N/A Semantic Scholar · N/A X · N/A Fetched 2026-09-19 14:26:06.878216 UTC

TL;DR - A Molecular Cell study identifies Ewing sarcoma as an MMEJ-deficient cancer and shows that EWS-FLI1 disables POLQ/Pol θ through defective exon 25 splicing and impaired DNA-repair foci formation. This creates targetable dependencies on alternative DNA-repair pathways and may provide a biomarker for treatment selection.

  • EWSR1, FUBP1, and KHSRP normally bind a six-nucleotide enhancer in POLQ exon 25 to preserve correct splicing and functional Pol θ expression.
  • EWS-FLI1 sequesters EWSR1 away from this enhancer, causing exon 25 skipping, while independently disrupting Pol θ recruitment to mitotic DNA-break sites.
  • Correcting POLQ splicing restored MMEJ activity and reversed sensitivity to DNA-repair inhibitors, establishing a direct causal link.
  • Ewing sarcoma models were selectively vulnerable to RBM39 degraders, CDK12 inhibitors, and DNA-PK inhibition combined with etoposide.
item →